{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:15:41Z","timestamp":1769717741007,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Anhui Provincial Health Research Project of 2023","award":["AHWJ2023A20224"],"award-info":[{"award-number":["AHWJ2023A20224"]}]},{"name":"Clinical cultivation project of the second Hospital of Anhui Medical University","award":["2021LCYB11"],"award-info":[{"award-number":["2021LCYB11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10067-025-07768-3","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T07:13:41Z","timestamp":1762931621000},"page":"139-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics, associated factors, and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus: a case\u2013control study"],"prefix":"10.1007","volume":"45","author":[{"given":"Lin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hexiang","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0936-8269","authenticated-orcid":false,"given":"Long","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"3","key":"7768_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/practneurol-2021-003194","volume":"22","author":"JD Triplett","year":"2022","unstructured":"Triplett JD, Kutlubaev MA, Kermode AG, Hardy T (2022) Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol 22(3):183\u2013189. https:\/\/doi.org\/10.1136\/practneurol-2021-003194","journal-title":"Pract Neurol"},{"issue":"9","key":"7768_CR2","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","volume":"14","author":"JE Fugate","year":"2015","unstructured":"Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neuro 14(9):914\u2013925. https:\/\/doi.org\/10.1016\/S1474-4422(15)00111-8","journal-title":"Lancet Neuro"},{"issue":"5","key":"7768_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4065\/mcp.2009.0590","volume":"85","author":"JE Fugate","year":"2010","unstructured":"Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85(5):427\u2013432. https:\/\/doi.org\/10.4065\/mcp.2009.0590","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"7768_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ane.12213","volume":"130","author":"TG Liman","year":"2014","unstructured":"Liman TG, Bohner G, Endres M, Siebert E (2014) Discharge status and in-hospital mortality in posterior reversible encephalopathy syndrome. Acta Neurol Scand 130(1):34\u201339. https:\/\/doi.org\/10.1111\/ane.12213","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"7768_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/0961203313496341","volume":"22","author":"SM Jung","year":"2013","unstructured":"Jung SM, Moon SJ, Kwok SK, Ju JH, Park KS, Park SH, Kim H-Y (2013) Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lupus 22(9):885\u2013891. https:\/\/doi.org\/10.1177\/0961203313496341","journal-title":"Lupus"},{"issue":"8","key":"7768_CR6","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1097\/RHU.0000000000001470","volume":"27","author":"A Manadan","year":"2021","unstructured":"Manadan A, Kambhatla S, Gauto-Mariotti E, Okoli C, Block JA (2021) Rheumatic diseases associated with posterior reversible encephalopathy syndrome. J Clin Rheumatol 27(8):e391\u2013e394. https:\/\/doi.org\/10.1097\/RHU.0000000000001470","journal-title":"J Clin Rheumatol"},{"key":"7768_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00071","volume":"11","author":"A Hinduja","year":"2020","unstructured":"Hinduja A (2020) Posterior reversible encephalopathy syndrome: clinical features and outcome. Front Neurol 11:71. https:\/\/doi.org\/10.3389\/fneur.2020.00071","journal-title":"Front Neurol"},{"issue":"2","key":"7768_CR8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ekir.2017.10.017","volume":"3","author":"K Ganesh","year":"2017","unstructured":"Ganesh K, Nair RR, Kurian G, Mathew A, Sreedharan S, Paul Z (2017) Posterior reversible encephalopathy syndrome in kidney disease. Kidney Int Rep 3(2):502\u2013507. https:\/\/doi.org\/10.1016\/j.ekir.2017.10.017","journal-title":"Kidney Int Rep"},{"key":"7768_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-12-152","volume":"12","author":"B Liu","year":"2012","unstructured":"Liu B, Zhang X, Zhang FC, Yao Y, Zhou RZ, Xin MM et al (2012) Posterior reversible encephalopathy syndrome could be an underestimated variant of \u201creversible neurological deficits\u201d in Systemic Lupus Erythematosus. BMC Neurol 12:152. https:\/\/doi.org\/10.1186\/1471-2377-12-152","journal-title":"BMC Neurol"},{"issue":"11","key":"7768_CR10","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/acr.22047","volume":"65","author":"CC Lai","year":"2013","unstructured":"Lai CC, Chen WS, Chang YS, Wang SH, Huang CJ, Guo WY et al (2013) Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 65(11):1766\u20131774. https:\/\/doi.org\/10.1002\/acr.22047","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"7768_CR11","doi-asserted-by":"publisher","first-page":"300060521102976","DOI":"10.1177\/03000605211029766","volume":"49","author":"DL Hao","year":"2021","unstructured":"Hao DL, Yang YL, Zhou LM, Liu QM, Liu R, Ke Xu et al (2021) Systemic lupus erythematosus complicatedwith reversible posterior encephalopathy syndrome: a case report. J Int Med Re 49(7):3000605211029766. https:\/\/doi.org\/10.1177\/03000605211029766","journal-title":"J Int Med Re"},{"issue":"5","key":"7768_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/09612033221088207","volume":"31","author":"R Baisya","year":"2022","unstructured":"Baisya R, Devarasetti PK, Narayanan R, Rajasekhar L (2022) Posterior reversible encephalopathy syndrome in juvenile lupus- a case series and literature review. Lupus 31(5):606\u2013612. https:\/\/doi.org\/10.1177\/09612033221088207","journal-title":"Lupus"},{"issue":"2","key":"7768_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/0961203307085405","volume":"17","author":"G Leroux","year":"2008","unstructured":"Leroux G, Sellam J, Costedoat-Chalumeau N, Le Thi Huong D, Combes A, Tieuli\u00e9 N et al (2008) Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 17(2):139\u2013147. https:\/\/doi.org\/10.1177\/0961203307085405","journal-title":"Lupus"},{"issue":"8","key":"7768_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1177\/0961203319856416","volume":"28","author":"HW Cui","year":"2019","unstructured":"Cui HW, Lei RY, Zhang SG, Han LS, Zhang BA (2019) Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study. Lupus 28(8):961\u2013969. https:\/\/doi.org\/10.1177\/0961203319856416","journal-title":"Lupus"},{"key":"7768_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9401661","volume":"14","author":"HW Cui","year":"2022","unstructured":"Cui HW, Lei RY, Zhang BA (2022) Clinical features and risk factors of mortality in patients with posterior reversible encephalopathy syndrome. Behav Neurol 14:2022:9401661. https:\/\/doi.org\/10.1155\/2022\/9401661","journal-title":"Behav Neurol"},{"key":"7768_CR16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10195","volume":"12","author":"EN Hartman","year":"2020","unstructured":"Hartman EN, Tuna K, Monsour E, Komanduri K, Tarasiuk-Rusek A (2020) Seizure as an initial presentation for posterior reversible encephalopathy syndrome in undiagnosed systemic lupus erythematosus and lupus nephritis: a case report. Cureus 12:e10195. https:\/\/doi.org\/10.7759\/cureus.10195","journal-title":"Cureus"},{"issue":"4","key":"7768_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.clineuro.2008.11.017","volume":"111","author":"JF Baizabal-Carvallo","year":"2009","unstructured":"Baizabal-Carvallo JF, Barragan-Campos HM, Padilla-Aranda HJ, Alonso-Juarez M, Estanol B, Cantu-Brito C, Garc\u00eda-Ramos G (2009) Posterior reversible encephalopathy syndrome as a complication of acute lupus activity. Clin Neurol Neurosurg 111(4):359\u2013363. https:\/\/doi.org\/10.1016\/j.clineuro.2008.11.017","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"7768_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10067-017-3892-2","volume":"37","author":"U Damrongpipatkul","year":"2018","unstructured":"Damrongpipatkul U, Oranratanachai K, Kasitanon N, Wuttiplakorn S, Louthrenoo W (2018) Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study. Clin Rheumatol 37(3):691\u2013702. https:\/\/doi.org\/10.1007\/s10067-017-3892-2","journal-title":"Clin Rheumatol"},{"issue":"9","key":"7768_CR19","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"7768_CR20","doi-asserted-by":"crossref","unstructured":"(1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum Arthritis Rheum 42(4):599\u2013608. 10.1002\/1529-0131(199904)42:4<599:AID-ANR2>3.0.CO;2-F","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"issue":"11","key":"7768_CR21","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1002\/art.20583","volume":"5","author":"F Buttgereit","year":"2014","unstructured":"Buttgereit F, Straub RH, Wehling M, Burmester GR (2014) Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum 5(11):3408\u20133417. https:\/\/doi.org\/10.1002\/art.20583","journal-title":"Arthritis Rheum"},{"issue":"8","key":"7768_CR22","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.jstrokecerebrovasdis","volume":"23","author":"LC Porcello Marrone","year":"2014","unstructured":"Porcello Marrone LC, Gadonski G, de Oliveira LG, da Costa BEP, Torres Lopes MFF, Farina Brunelli JP, Diogo LP, Huf Marrone AC, Da Costa JC (2014) Blood-brain barrier breakdown in reduced uterine perfusion pressure: A possible model of posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis 23(8):2075\u20132079. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"7768_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/practneurol-2011-000010","volume":"11","author":"C Roth","year":"2011","unstructured":"Roth C, Ferbert A (2011) The posterior reversible encephalopathy syndrome: what\u2019s certain, what\u2019s new? Pract Neurol 11(3):136\u2013144. https:\/\/doi.org\/10.1136\/practneurol-2011-000010","journal-title":"Pract Neurol"},{"issue":"3","key":"7768_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/rheumatology\/kem319","volume":"47","author":"A Mak","year":"2008","unstructured":"Mak A, Chan BPL, Yeh IB, Ho RCM, Boey ML, Feng PH, Koh DR, Ong BKC (2008) Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma. Rheumatology (Oxford) 47(3):256\u2013262. https:\/\/doi.org\/10.1093\/rheumatology\/kem319","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"7768_CR25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3174\/ajnr.A0929","volume":"29","author":"WS Bartynski","year":"2008","unstructured":"Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part II: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29(6):1043\u20131049. https:\/\/doi.org\/10.3174\/ajnr.A0929","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6\u20137","key":"7768_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neurol.2016.06.004","volume":"172","author":"A Chardain","year":"2016","unstructured":"Chardain A, Mesnage V, Alamowitch S, Bourdain F, Crozier S, Lenglet T et al (2016) Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: a frequent association? Rev Neurol (Paris) 172(6\u20137):384\u2013388. https:\/\/doi.org\/10.1016\/j.neurol.2016.06.004","journal-title":"Rev Neurol (Paris)"},{"key":"7768_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.seizure.2020.01.003","volume":"76","author":"X Fang","year":"2020","unstructured":"Fang X, Wang H, Liu Z, Chen J, Tan H, Liang Y et al (2020) Posterior reversible encephalopathy syndrome in preeclampsia and eclampsia: the role of hypomagnesemia. Seizure 76:12\u201316. https:\/\/doi.org\/10.1016\/j.seizure.2020.01.003","journal-title":"Seizure"},{"issue":"6","key":"7768_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061724","volume":"19","author":"K Kostov","year":"2018","unstructured":"Kostov K, Halacheva L (2018) Role of magnesium deficiency in promoting atherosclerosis, endothelial dysfunction, and arterial stiffening as risk factors for hypertension. Int J Mol Sci 19(6):1724. https:\/\/doi.org\/10.3390\/ijms19061724","journal-title":"Int J Mol Sci"},{"issue":"10","key":"7768_CR29","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/s41440-023-01404-w","volume":"46","author":"R Parsanathan","year":"2023","unstructured":"Parsanathan R (2023) Trace element magnesium: a key player in hypertension management. Hypertens Res 46(10):2442\u20132444. https:\/\/doi.org\/10.1038\/s41440-023-01404-w","journal-title":"Hypertens Res"},{"issue":"6","key":"7768_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.semarthrit.2006.01.002","volume":"35","author":"MD Magnano","year":"2006","unstructured":"Magnano MD, Bush TM, Herrera I, Altman RD (2006) Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 35(6):396\u2013402. https:\/\/doi.org\/10.1016\/j.semarthrit.2006.01.002","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"7768_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.semarthrit.2011.07.001","volume":"41","author":"CE Barber","year":"2011","unstructured":"Barber CE, Leclerc R, Gladman DD, Urowitz MB, Fortin PR (2011) Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus. Semin Arthritis Rheum 41(3):353\u2013363. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.07.001","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"7768_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1157-0","volume":"18","author":"F Verhoeven","year":"2016","unstructured":"Verhoeven F, Prati C, Maguin-Gat\u00e9 K, Wendling D, Demougeot C (2016) Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis. Arthritis Res Ther 18(1):258. https:\/\/doi.org\/10.1186\/s13075-016-1157-0","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"7768_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/RHU.0b013e3182a21ffd","volume":"19","author":"N Gatla","year":"2013","unstructured":"Gatla N, Annapureddy N, Sequeira W, Jolly M (2013) Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol 19(6):334\u2013340. https:\/\/doi.org\/10.1097\/RHU.0b013e3182a21ffd","journal-title":"J Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07768-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07768-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07768-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:41:27Z","timestamp":1769679687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07768-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7768"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07768-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the Second Affiliated Hospital of Anhui Medical\u00a0University (approval No. YX2025-203). All procedures were carried out in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}